Hermetica Superfood Encyclopedia
The Short Answer
Trametes pubescens fruiting bodies contain phenolic compounds—notably gallic acid (18.8 μg/g) and epigallocatechin gallate (14.8 μg/g)—alongside β-glucans (approximately 42% of biomass) that collectively drive antioxidant, enzyme-inhibitory, and anti-inflammatory activity. In vitro, methanol and hot water extracts achieve up to 96% DPPH radical scavenging at 6 mg/mL and inhibit acetylcholinesterase by 51.70–90.94% at 0.063–1.0 mg/mL, though no human clinical trials have yet validated these effects.
CategoryMushroom
GroupMushroom/Fungi
Evidence LevelPreliminary
Primary KeywordTrametes pubescens benefits
Hairy Bracket Mushroom — botanical close-up
Health Benefits
**Antioxidant Protection**
Hot water extracts (HWE) demonstrate DPPH radical scavenging activity comparable to the synthetic antioxidant BHT at 6 mg/mL, attributed primarily to gallic acid, epigallocatechin gallate, and caffeic acid, which donate hydrogen atoms to neutralize free radicals.
**Anti-Diabetic Enzyme Inhibition**
Methanol and hot water extracts moderately inhibit α-amylase and α-glucosidase at 2.0 mg/mL, reducing the rate of dietary carbohydrate breakdown and potentially blunting postprandial glucose spikes, though inhibitory potency is lower than the reference drug acarbose.
**Cognitive Support via Cholinesterase Inhibition**
Methanol extract inhibits acetylcholinesterase (AChE) by 51.70–90.94% and butyrylcholinesterase (BChE) by 49.49–75.73% across 0.063–1.0 mg/mL concentrations, a mechanism central to preserving acetylcholine levels relevant to dementia pathology, with gallic acid and naringin implicated as active contributors.
**Anti-Inflammatory Activity**
Fruiting body and biomass extracts dose-dependently suppress lipopolysaccharide (LPS)-induced nitric oxide (NO) production in RAW 264.7 murine macrophages at 0.5–2 mg/mL, indicating modulation of the innate inflammatory signaling cascade through phenolic constituents.
**Immune Modulation via β-Glucans**
The fruiting body biomass contains approximately 42% β-glucan (1.713 mg/mL in biomass extract), which interacts with pattern-recognition receptors such as Dectin-1 on immune cells to promote cytokine regulation and macrophage activation, consistent with mechanisms documented for related Trametes species.
**Ferric Ion Reduction**
HWE exhibits ferric reducing antioxidant power (FRAP) approaching BHT levels at 6 mg/mL, suggesting the capacity to chelate transition metals and suppress oxidative stress pathways driven by iron-catalyzed Fenton reactions.
**Phenolic-Rich Phytochemical Profile**
The fruiting body contains 11 quantified phenolic compounds totaling 86.61 μg/g, including rutin hydrate (7.11 μg/g) and protocatechuic acid (2.92 μg/g), compounds known to modulate NF-κB signaling and support vascular and metabolic homeostasis based on broader literature.
Origin & History
Natural habitat
Trametes pubescens is a white-rot polypore fungus distributed across temperate and subtropical regions of Europe, North America, and Asia, where it colonizes dead or dying hardwood trees such as oak, beech, and birch. It thrives in moist woodland environments, fruiting on exposed logs and fallen timber throughout spring to autumn. The species has not been cultivated historically for medicinal purposes but can be propagated under laboratory conditions via submerged fermentation for biomass production rich in bioactive polysaccharides.
“Trametes pubescens has not been documented as a medicinal species in any major traditional medicine system, including Traditional Chinese Medicine, Ayurveda, or European herbalism, distinguishing it from its close relative Trametes versicolor (Turkey Tail), which carries a centuries-long history of use in East Asian medicine. The species has been recognized primarily in ecological and mycological literature as a wood-decaying saprotroph contributing to nutrient cycling in forest ecosystems rather than as a therapeutic agent. Its common name, 'hairy bracket mushroom,' derives from the distinctive pubescent (fine-haired) surface of its fruiting bodies, which has been noted in taxonomic descriptions since Schumacher's original classification and Fries's subsequent formal nomenclature. Modern scientific interest in T. pubescens is recent, emerging from broader ethnopharmacological screening of polypore fungi for bioactive compounds in the early twenty-first century rather than from any established ethnomedicinal tradition.”Traditional Medicine
Scientific Research
The existing evidence base for Trametes pubescens is confined exclusively to in vitro studies, with no published human clinical trials or animal pharmacokinetic studies identified in available literature as of 2024. Key studies have employed DPPH radical scavenging assays, ferric reducing power (FRAP), enzyme inhibition assays (α-amylase, α-glucosidase, AChE, BChE), and LPS-stimulated RAW 264.7 macrophage models to characterize bioactivity across methanol extracts (ME) and hot water extracts (HWE) at concentrations of 0.063–6 mg/mL. Phenolic compound identification and quantification have been performed by HPLC, yielding precise measurements of 11 compounds in fruiting bodies, while submerged biomass fermentation studies have characterized β-glucan, saponin, flavonoid, and anthraquinone content. The evidence is preliminary and hypothesis-generating; mechanistic extrapolation to human physiology is not yet supported, and interspecies comparisons with the better-studied Trametes versicolor should be made cautiously given compositional and pharmacological differences between species.
Preparation & Dosage
**Hot Water Extract (HWE)**
2–6 mg/mL in vitro; decoction preparation involves prolonged boiling of dried fruiting bodies to solubilize polar phenolics and β-glucans; no human dose established
Used in research at .
**Methanol Extract (ME)**
0 mg/mL in vitro for enzyme inhibition and radical scavenging assays; not suitable for direct human consumption in solvent form; alcohol precipitation or evaporation steps required for any food-grade adaptation
Employed at 0.063–2..
**Submerged Fermentation Biomass Extract**
713 mg/mL); offers scalable production; no standardized supplement form or human dose currently established
Yields β-glucan-rich extracts (42% dry weight β-glucan, 1..
**Dried Fruiting Body Powder**
Contains 86.61 μg/g total phenolics; theoretical starting material for capsule formulations by analogy with related Trametes species, but no validated dosing protocol exists.
**Standardization Note**
No commercially standardized extract exists for T. pubescens; related T. versicolor products are standardized to 30–40% polysaccharides, which may serve as a conceptual benchmark pending species-specific research.
**Timing**
No human pharmacokinetic data available; no evidence-based guidance on optimal administration timing or fasting state requirements.
Nutritional Profile
Fruiting bodies contain a total of 11 quantified phenolic compounds at 86.61 μg/g dry weight, with gallic acid (18.8 μg/g), epigallocatechin gallate (14.8 μg/g), rutin hydrate (7.11 μg/g), caffeic acid (4.81 μg/g), and protocatechuic acid (2.92 μg/g) as the dominant constituents. β-Glucan represents approximately 42% of dry biomass weight (1.713 mg/mL in submerged culture extracts), making polysaccharides the predominant functional macromolecular class. Submerged biomass extracts additionally contain saponins (70.6 μg/mL), anthraquinones (14.5 μg/mL), total flavonoids (9.5–11.16 μg/mL), and total phenolics (12.45–12.7 μg/mL). Protein content is low at 0.0153 mg/mL in biomass extracts and 0.1088 mg/mL in mushroom extracts; trace triterpenoids and polyphenolics are also present. Bioavailability of phenolics from fungal matrices is not established for this species; gut microbiota metabolism of β-glucans and polyphenol absorption kinetics observed in related species suggest partial bioavailability, but species-specific data are absent.
How It Works
Mechanism of Action
The antioxidant effects of Trametes pubescens are mediated through hydrogen atom transfer and single electron transfer mechanisms driven by gallic acid, epigallocatechin gallate (EGCG), and caffeic acid, which quench DPPH and hydroxyl radicals and reduce ferric ions to ferrous form. The anti-dementia activity arises from competitive or mixed inhibition of acetylcholinesterase and butyrylcholinesterase by gallic acid and naringin, thereby slowing acetylcholine hydrolysis at cholinergic synapses and sustaining neurotransmitter availability. Anti-inflammatory effects involve downregulation of inducible nitric oxide synthase (iNOS) activity in macrophages stimulated with LPS, reducing NO production in a dose-dependent manner across 0.5–2 mg/mL extract concentrations, with phenolic compounds likely suppressing NF-κB-mediated transcription of pro-inflammatory mediators. β-Glucans present at approximately 42% of dry biomass bind to Dectin-1 and complement receptor 3 (CR3) on innate immune cells, triggering intracellular signaling through Syk kinase and CARD9 pathways to regulate cytokine output and enhance phagocytic activity.
Clinical Evidence
No clinical trials involving human subjects have been conducted on Trametes pubescens, and therefore no clinically validated efficacy data, effect sizes, or therapeutic outcomes exist for this species. All available mechanistic and bioactivity data originate from cell-free biochemical assays and single-cell macrophage models, which, while informative for hypothesis generation, cannot be extrapolated to predict clinical benefit, therapeutic dosage, or safety in human populations. The closest clinical parallel comes from Trametes versicolor, where polysaccharide-K (PSK) and polysaccharide peptide (PSP) extracts have demonstrated immunomodulatory and adjunctive anti-cancer effects in human trials, but these findings cannot be directly applied to T. pubescens without dedicated research. Confidence in any clinical benefit for T. pubescens remains very low, and the ingredient should be regarded as investigational pending adequately powered in vivo and human studies.
Safety & Interactions
No human safety data, adverse event reports, maximum tolerated doses, or pharmacovigilance information exist for Trametes pubescens, as all studies to date have been conducted in vitro. In vitro experiments at concentrations of 0.063–6 mg/mL show no reported cytotoxicity in the macrophage cell models tested, but in vitro non-toxicity cannot be extrapolated to human safety at supplemental doses. No drug interaction data are available; however, by mechanistic inference, extracts inhibiting α-glucosidase could theoretically potentiate oral hypoglycemic agents, and cholinesterase-inhibitory activity could interact with anticholinergic medications or prescribed cholinesterase inhibitors such as donepezil. No guidance exists for use in pregnancy, lactation, pediatric populations, or individuals with immunocompromising conditions; until dedicated safety studies are conducted, use in these populations is not advisable.
Synergy Stack
Hermetica Formulation Heuristic
Also Known As
Trametes pubescens (Schumach.) Fr.Hairy Bracket MushroomPubescent Bracket FungusCoriolus pubescensPolyporus pubescens
Frequently Asked Questions
What is Trametes pubescens used for?
Trametes pubescens is investigated in laboratory settings for antioxidant, anti-diabetic, anti-dementia, and anti-inflammatory properties, primarily based on its phenolic compounds and β-glucan content. Methanol and hot water extracts have demonstrated acetylcholinesterase inhibition of up to 90.94% and DPPH radical scavenging comparable to the synthetic antioxidant BHT at 6 mg/mL in vitro. No human clinical applications have been established, and it is not currently used as a standardized supplement or therapeutic agent.
How does Trametes pubescens differ from Trametes versicolor (Turkey Tail)?
While both are polypore fungi in the Trametes genus containing β-glucans and phenolic compounds, Trametes versicolor has an extensive research record including human clinical trials supporting its polysaccharide-K (PSK) as an adjunctive cancer immunotherapy, whereas T. pubescens has only in vitro data with no clinical trials. T. pubescens is distinguished morphologically by its pubescent (hairy) cap surface and has not been documented in traditional medicine, unlike T. versicolor's centuries of use in East Asian medicine. Compositional differences mean that pharmacological findings from T. versicolor cannot be directly applied to T. pubescens.
What bioactive compounds are found in Trametes pubescens?
Trametes pubescens fruiting bodies contain 11 quantified phenolic compounds totaling 86.61 μg/g, with gallic acid (18.8 μg/g) and epigallocatechin gallate (14.8 μg/g) as the most abundant. Submerged biomass extracts are particularly rich in β-glucans, which constitute approximately 42% of dry biomass weight, alongside saponins (70.6 μg/mL), flavonoids (9.5–11.16 μg/mL), and trace anthraquinones and triterpenoids. These compounds collectively account for the species' observed antioxidant, enzyme-inhibitory, and anti-inflammatory activities in cell-based experiments.
Is Trametes pubescens safe to consume?
No human safety studies, toxicological evaluations, or clinical trials have been conducted on Trametes pubescens, making it impossible to confirm its safety profile for supplemental use at this time. In vitro experiments have not reported cytotoxicity at tested concentrations (0.063–6 mg/mL), but this cannot be extrapolated to human safety. Individuals taking hypoglycemic medications or cholinesterase inhibitors should exercise particular caution given the mechanistic overlap with the extract's inhibitory activities, and pregnant or lactating individuals should avoid use until adequate safety data are available.
What is the recommended dosage of Trametes pubescens?
No established human dosage exists for Trametes pubescens, as all efficacy data derive from in vitro studies using methanol and hot water extracts at concentrations of 0.063–6 mg/mL, which are laboratory research concentrations rather than human dose equivalents. No commercial supplement product standardized to T. pubescens bioactives is currently available, and no pharmacokinetic studies have determined bioavailability or safe dosing ranges. Until clinical trials are conducted, any supplemental use would be experimental and without evidence-based dosing guidance.
How do different extraction methods affect the potency of Trametes pubescens?
Hot water extraction (HWE) and methanol extraction methods yield different bioactive profiles from Trametes pubescens, with hot water extracts demonstrating DPPH radical scavenging activity comparable to the synthetic antioxidant BHT at 6 mg/mL. Methanol extracts show moderate inhibition of α-amylase and α-glucosidase enzymes, making extraction method selection important for targeting specific health benefits. The choice between extraction methods should consider whether antioxidant protection or anti-diabetic enzyme inhibition is the primary intended use.
What are the primary phenolic compounds responsible for Trametes pubescens health benefits?
Trametes pubescens contains three key phenolic compounds—gallic acid, epigallocatechin gallate (EGCG), and caffeic acid—that work by donating hydrogen atoms to neutralize free radicals and provide antioxidant protection. These compounds are the primary drivers of the mushroom's DPPH radical scavenging activity and contribute to its anti-diabetic enzyme inhibition properties. Understanding these specific compounds helps explain why Trametes pubescens demonstrates measurable bioactivity in both antioxidant and glucose-metabolism research.
Does Trametes pubescens have clinically proven benefits for blood sugar management?
Research shows that both methanol and hot water extracts of Trametes pubescens moderately inhibit α-amylase and α-glucosidase enzymes, which are key targets for managing postprandial glucose spikes and supporting blood sugar balance. These enzyme-inhibition properties suggest potential anti-diabetic activity, though results are classified as moderate rather than potent compared to pharmaceutical alternatives. While the mechanism is well-documented in vitro, more human clinical trials are needed to establish the magnitude of blood sugar management benefits in real-world supplementation scenarios.
Explore the Full Encyclopedia
7,400+ ingredients researched, verified, and formulated for optimal synergy.
Browse IngredientsThese statements have not been evaluated by the Food and Drug Administration. This content is for informational purposes only and is not intended to diagnose, treat, cure, or prevent any disease.
hermetica-encyclopedia-canary-zzqv9k4w trametes-pubescens-trametes-pubescens-schumach-fr curated by Hermetica Superfoods at ingredients.hermeticasuperfoods.com and licensed CC BY-NC-SA 4.0 (non-commercial share-alike, attribution required)
